A comparison of misoprostol, controlled-release dinoprostone vaginal insert and oxytocin for cervical ripening

Arch Gynecol Obstet. 2011 Dec;284(6):1331-7. doi: 10.1007/s00404-011-1844-7. Epub 2011 Feb 3.

Abstract

Objective: We compared the safety and effectiveness of oxytocin, dinoprostone and misoprostol for cervical priming.

Study design: A total of 218 patients were enrolled to receive between one and three treatments according to physicians' options. The end points were: (1) vaginal delivery or Bishop score ≥ 8 at the end of 12 h, (2) vaginal delivery by 12 h or difference ≥ 4 between the initial and 12th hour Bishop scores. Statistical analyses were performed with ANOVA, Krustal Wallis, Scheffe, χ², Fisher, Advanced χ², and Kolmogorov-Smirnov tests. Tukey's HSD was used as a post hoc test.

Results: Misoprostol showed statistical significance for the rate of vaginal delivery <12 h, ≥ 8 Bishop score at the end of 12 h, and cervical change of ≥ 4 Bishop scores within 12 h (p = 0.013).

Conclusions: Comparison between cases Bishop score <4 showed that misoprostol is more effective than dinoprostone and oxytocin. Considering Bishop score = 0 cases we calculated no statistical significance.

Publication types

  • Comparative Study

MeSH terms

  • Administration, Intravaginal
  • Adolescent
  • Adult
  • Cervical Ripening / drug effects*
  • Delayed-Action Preparations
  • Dinoprostone / administration & dosage*
  • Dinoprostone / adverse effects
  • Female
  • Gestational Age
  • Humans
  • Labor, Induced*
  • Middle Aged
  • Misoprostol / administration & dosage*
  • Misoprostol / adverse effects
  • Oxytocics / administration & dosage*
  • Oxytocics / adverse effects
  • Oxytocin / administration & dosage*
  • Oxytocin / adverse effects
  • Pregnancy
  • Pregnancy Outcome
  • Prospective Studies
  • Treatment Outcome
  • Young Adult

Substances

  • Delayed-Action Preparations
  • Oxytocics
  • Misoprostol
  • Oxytocin
  • Dinoprostone